Difference between revisions of "Team:UCopenhagen"
| Line 103: | Line 103: | ||
<ul class="list-inline banner-social-buttons"> | <ul class="list-inline banner-social-buttons"> | ||
<li> | <li> | ||
| − | <a href="https://twitter.com/ | + | <a href="https://twitter.com/iGEM_Copenhagen" target="_blank" class="btn btn-default btn-lg"><i class="fa fa-twitter fa-fw"></i> <span class="network-name">Twitter</span></a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://www.facebook.com/ | + | <a href="https://www.facebook.com/iGEMCopenhagen" target="_blank" class="btn btn-default btn-lg"><i class="fa fa-facebook fa-fw"></i> <span class="network-name">Facebook</span></a> |
</li> | </li> | ||
<li> | <li> | ||
| − | <a href="https://www.instagram.com/ | + | <a href="https://www.instagram.com/igemku2017" target="_blank" class="btn btn-default btn-lg"><i class="fa fa-instagram fa-fw"></i> <span class="network-name">Instagram</span></a> |
</li> | </li> | ||
</ul> | </ul> | ||
Revision as of 13:03, 14 September 2017
<!DOCTYPE HTML>
Incell: a platform for synthetic endosymbiosis
Incell is a new synthetic biology platform with near future applications in research, industry and services. We are rewriting nature’s code for endosymbiosis and transforming an evolutionary phenomenon into a technology compatible with standard biological parts.
Our vision is to produce synthetic host–endosymbiont systems. We set out with a trinity of experiments intrinsic to the synthetic reconstruction of endosymbiosis. First, creating and sustaining dependence between a host and its endosymbionts by fulfilling the amino acid requirement of an auxotrophic host. Next, to build a modular system of cell-penetrating peptides for protein transport of host nuclear encoded proteins into an endosymbiont, recapitulating a crucial feature of the natural process. Finally, regulating the number of endosymbionts within a host using a CRISPR-Cas system for control of replication.
Further ahead we see a safe, customisable, sustainable technology providing biological solutions to present and future challenges in biotechnology, agriculture and medicine.
